Cedric Francois

Insider Reports History

Location
Crestwood, KY
Signature
/s/ David Watson, attorney-in-fact for Cedric Francois
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cedric Francois:

Company Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Chief Executive Officer, Director Common Stock 472,065 $11,858,320 $25.12 03 Feb 2026 Indirect Owner (The Cedric Francois Irrevocable Trust of 2023)
Apellis Pharmaceuticals, Inc. Chief Executive Officer, Director Common Stock 307,946 $7,735,634 $25.12 03 Feb 2026 Indirect Owner (The Cedric Francois Irrevocable Trust of 2023 - 2)
Apellis Pharmaceuticals, Inc. Chief Executive Officer, Director Common Stock 300,000 $7,536,030 $25.12 03 Feb 2026 Indirect Owner (The Francois Grossi Trust)
Apellis Pharmaceuticals, Inc. Chief Executive Officer, Director Common Stock 234,411 $5,888,427 $25.12 03 Feb 2026 Indirect Owner (The Francois-DuBois Educational Trust)
Apellis Pharmaceuticals, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 0 $5,574,625 $19.39 03 Feb 2026 Direct
Apellis Pharmaceuticals, Inc. Chief Executive Officer, Director Common Stock 490,837 $1,845,547 $3.76 03 Feb 2026 Direct

Insider Reports Filed by Cedric Francois

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APLS Apellis Pharmaceuticals, Inc. 03 Feb 2026 2 +$33,238 4 Chief Executive Officer, Director 05 Feb 2026, 16:14
APLS Apellis Pharmaceuticals, Inc. 28 Jan 2026 1 $0 4 Chief Executive Officer, Director 30 Jan 2026, 16:05
APLS Apellis Pharmaceuticals, Inc. 22 Jan 2026 1 -$591,845 4 Chief Executive Officer, Director 23 Jan 2026, 16:09
APLS Apellis Pharmaceuticals, Inc. 20 Jan 2026 1 -$161,946 4 Chief Executive Officer, Director 21 Jan 2026, 16:14
APLS Apellis Pharmaceuticals, Inc. 13 Jan 2026 1 -$225,999 4 Chief Executive Officer, Director 15 Jan 2026, 16:31
APLS Apellis Pharmaceuticals, Inc. 27 Aug 2025 2 -$6,352,743 4 Chief Executive Officer, Director 29 Aug 2025, 16:19
APLS Apellis Pharmaceuticals, Inc. 17 Jul 2025 3 -$359,958 4 Chief Executive Officer, Director 18 Jul 2025, 16:02
APLS Apellis Pharmaceuticals, Inc. 14 Jul 2025 6 -$2,528,619 4 Chief Executive Officer, Director 16 Jul 2025, 16:11
APLS Apellis Pharmaceuticals, Inc. 09 Jun 2025 1 +$5,574,625 4 Chief Executive Officer, Director 11 Jun 2025, 16:21
APLS Apellis Pharmaceuticals, Inc. 29 Jan 2025 1 -$83,375 4 Chief Executive Officer, Director 30 Jan 2025, 12:03
APLS Apellis Pharmaceuticals, Inc. 22 Jan 2025 1 -$412,296 4 Chief Executive Officer, Director 23 Jan 2025, 15:28
APLS Apellis Pharmaceuticals, Inc. 17 Jan 2025 2 -$179,959 4 Chief Executive Officer, Director 21 Jan 2025, 16:04
APLS Apellis Pharmaceuticals, Inc. 13 Jan 2025 1 -$179,302 4 Chief Executive Officer, Director 14 Jan 2025, 16:18
APLS Apellis Pharmaceuticals, Inc. 01 Nov 2024 1 $0 4 Chief Executive Officer, Director 01 Nov 2024, 18:43
APLS Apellis Pharmaceuticals, Inc. 01 Mar 2024 9 -$14,978,706 4 Chief Executive Officer, Director 05 Mar 2024, 16:07
APLS Apellis Pharmaceuticals, Inc. 12 Feb 2024 1 -$268,492 4 Chief Executive Officer, Director 13 Feb 2024, 16:49
APLS Apellis Pharmaceuticals, Inc. 29 Jan 2024 1 -$182,345 4 Chief Executive Officer, Director 31 Jan 2024, 16:26
APLS Apellis Pharmaceuticals, Inc. 22 Jan 2024 1 -$872,961 4 Chief Executive Officer, Director 23 Jan 2024, 19:28
APLS Apellis Pharmaceuticals, Inc. 16 Jan 2024 3 +$6,425,980 4 Chief Executive Officer, Director 17 Jan 2024, 16:32
APLS Apellis Pharmaceuticals, Inc. 21 Nov 2023 1 -$244,000 4 Chief Executive Officer, Director 21 Nov 2023, 17:36
APLS Apellis Pharmaceuticals, Inc. 19 Sep 2023 2 $0 4 Chief Executive Officer, Director 20 Sep 2023, 16:26
APLS Apellis Pharmaceuticals, Inc. 01 Sep 2023 4 -$5,461,959 4 Chief Executive Officer, Director 01 Sep 2023, 16:05
APLS Apellis Pharmaceuticals, Inc. 24 May 2023 2 $0 4 Chief Executive Officer, Director 25 May 2023, 16:44
APLS Apellis Pharmaceuticals, Inc. 16 May 2023 10 -$2,436,400 4 Chief Executive Officer, Director 18 May 2023, 17:10
APLS Apellis Pharmaceuticals, Inc. 27 Apr 2023 2 $0 4 Chief Executive Officer, Director 28 Apr 2023, 16:15
APLS Apellis Pharmaceuticals, Inc. 18 Apr 2023 5 -$2,327,220 4 Chief Executive Officer, Director 20 Apr 2023, 16:51
APLS Apellis Pharmaceuticals, Inc. 03 Apr 2023 6 $0 4 Chief Executive Officer, Director 05 Apr 2023, 17:56
APLS Apellis Pharmaceuticals, Inc. 21 Mar 2023 9 -$1,272,821 4 Chief Executive Officer, Director 23 Mar 2023, 16:55
APLS Apellis Pharmaceuticals, Inc. 27 Feb 2023 2 +$376,000 4 Chief Executive Officer, Director 01 Mar 2023, 15:10
APLS Apellis Pharmaceuticals, Inc. 21 Feb 2023 3 -$93,717 4 Chief Executive Officer 22 Feb 2023, 05:40
APLS Apellis Pharmaceuticals, Inc. 10 Feb 2023 1 -$202,689 4 Chief Executive Officer, Director 14 Feb 2023, 15:42
APLS Apellis Pharmaceuticals, Inc. 27 Jan 2023 1 -$151,925 4 Chief Executive Officer, Director 30 Jan 2023, 15:59
APLS Apellis Pharmaceuticals, Inc. 20 Jan 2023 1 -$492,029 4 Chief Executive Officer, Director 24 Jan 2023, 16:17
APLS Apellis Pharmaceuticals, Inc. 25 Apr 2022 3 +$6,903,357 4 Chief Executive Officer, Director 17 Jan 2023, 18:37
APLS Apellis Pharmaceuticals, Inc. 25 Apr 2022 9 -$1,236,304 4 Chief Executive Officer, Director 21 Dec 2022, 15:13
APLS Apellis Pharmaceuticals, Inc. 10 Feb 2022 1 -$118,884 4 Chief Executive Officer, Director 14 Feb 2022, 17:20
APLS Apellis Pharmaceuticals, Inc. 28 Jan 2022 1 -$78,106 4 Chief Executive Officer, Director 01 Feb 2022, 17:00
APLS Apellis Pharmaceuticals, Inc. 21 Jan 2022 2 $0 4 Chief Executive Officer, Director 25 Jan 2022, 15:58
APLS Apellis Pharmaceuticals, Inc. 31 Dec 2021 1 $0 5 Chief Executive Officer, Director 10 Feb 2022, 15:47
APLS Apellis Pharmaceuticals, Inc. 21 Jul 2021 2 +$62,107 4 Chief Executive Officer, Director 22 Jul 2021, 16:04